Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL584943 | 0.97 | DAO (0.34) | DAOCYP11B1CYP11B2DGAT1 | |
| SCHEMBL15627263 | 0.83 | CYP11B1 (0.36) | CYP11B1CYP11B2 | |
| SCHEMBL13550081 | 0.81 | PTGS2 (0.30) | — | |
| SCHEMBL30047939 | 0.81 | DGAT1 (0.31) | DGAT1 | |
| SCHEMBL28906499 | 0.81 | DGAT1 (0.31) | DGAT1 | |
| SCHEMBL22444782 | 0.81 | NMT1 (0.33) | — | |
| SCHEMBL18099485 | 0.81 | DGAT1 (0.31) | DGAT1 | |
| SCHEMBL21081880 | 0.81 | TRPV4 (0.45) | — | |
| SCHEMBL2395180 | 0.80 | — | — | |
| SCHEMBL20638975 | 0.77 | ERN1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0568040-B1 | Cyclohexane derivative and liquid crystal composition containing the same | CHISSO CORP (JP) | 1996-12-04 | — | — | EP | disclosed |
| US-5468421-A | Cyclohexane derivative and liquid crystal composition containing the same | CHISSO CORPORATION (JP) | 1995-11-21 | — | — | US | disclosed |
| EP-0568040-A1 | Cyclohexane derivative and liquid crystal composition containing the same | CHISSO CORPORATION (JP) | 1993-11-03 | — | — | EP | disclosed |